Correlation of Gene Status and Clinical Outcomes in ESCC | NCT03831828

Studies
Correlation of Gene Status and Clinical Outcomes in ESCC

NCT03831828

Sponsor

LiuJunFeng

Status

Unknown status

Last Update Posted

Feb 8, 2019Actual

Enrollment

46Estimated

Phase

Not provided

Conditions

Prognosis of Patients With ESCC

Interventions

Not provided

Countries

China

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Sep 2018

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Dec 26, 2018Actual

Primary Completion Date

Apr 1, 2019Estimated

Completion Date

Apr 1, 2019Estimated

First Submitted Date

Feb 4, 2019

First Submission Date that Met QC Criteria

Feb 4, 2019

First Posted Date

Feb 6, 2019Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Feb 6, 2019

Last Update Posted Date

Feb 8, 2019Actual

Name	Class
OrigiMed	INDUSTRY

Description Module

Brief Summary

The incidence of esophageal squamous cell carcinoma is highly regional and familial. The current treatment plan is based on the stage and location of the tumor.By studying the relationship between the status of different genes and prognosis, it can help doctors to develop precise and individualized treatment plans.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

46Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Lymph node metastasis Positive		good prognosis; without Lymph node metastasis.
Lymph node metastasis Negative		poor prognosis; with Lymph node metastasis.

Interventions

Not provided

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Gene test	466 Tumor-associated gene test by next-generation sequencing(NGS)	2019-2 to 2019-4

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Esophageal cancer patients who underwent surgery treatment, and postoperative pathological diagnosis was squamous cell carcinoma. Patients with ESCC have complete clinical information.

Exclusion Criteria:

Patients who also suffering from other tumors.

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

30 Years

Maximum Age

80 Years

Standard Ages

AdultOlder Adult

Study Population

Taihang Mountain area population in northern China.

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Junfeng Liu, MD	Contact	13931152296		13931152296@163.com

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Junfeng Liu	Recruiting	Shijiazhuang	Hebei	050000	China